Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
national blog main
new york blog main
new york top stories
2
×
alirocumab
alnylam pharmaceuticals
amgen
azacitidine
beta-thalassemia
boston
boston top stories
clinical trials
dacogen
deals
decitabine
dna
drugs
epigenetics
epizyme
evercore isi
evolocumab
farydak
flagship pioneering
fulcrum therapeutics
heart attack
inclisiran
insulated genomic domains
joseph swartz
kaleido biosciences
mahesh karande
medicines co.
national top stories
new york
omega therapeutics
panobinostat
pcsk9 inhibitors
regeneron pharmaceuticals
richard young
What
based
2
×
medicines
2
×
new
aims
alnylam
approach
biotech
called
cholesterol
data
debuts
developing
drug
drugs
epigenetic
epigenetics
evidence
field
flagship’s
heart
lasting
long
looms
lowering
medco
morning
omega
partner
pharmaceuticals
presented
reckoning
research
rna
startup
step
supporting
term
therapeutics
touting
touts
Language
unset
Current search:
xconomy.com
×
based
×
medicines
×
" new york top stories "
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms